HOXA9 and hematopoietic and lymphoid system neoplasm: As HOXA9 plays a pro-carcinogenic role in blood cancer, identification of the factor that mediates the “switching” of HOXA9 as an oncogene or a tumor suppressor would be of particular value to understand and potentially treat disparate oncogenesis.